Effects of lercanidipine on traumatic spinal cord injury: an experimental study
Turkish Journal of Trauma and Emergency Surgery · 2024
DOI: 10.14744/tjtes.2024.03660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Trauma and Emergency Surgery, 2024. Verfasst von Çağlar Türk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tepecik Research and Training Hospital, University of Health Sciences, İzmir-Türkiye. Hauptthemen laut MEDLINE: Neuroprotective Agents, Spinal Cord Injuries, Dihydropyridines. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Spinal cord injury is a devastating trauma that leaves survivors at risk for several medical complications throughout their lives. Lercanidipine, a third-generation calcium channel blocker, possesses anti-apoptotic, anti-inflammatory, and antioxidative properties. This study aimed to evaluate the neuroprotective effects of lercanidipine in an experimental spinal cord trauma model. METHODS: Twenty-one Wistar rats were randomly assigned to three groups. Group 1 (G1) underwent laminectomy. Group 2 (G2) were subjected to trauma following laminectomy. Group 3 (G3) were exposed to trauma following laminectomy and treated with lercanidipine. Lercanidipine was administered intraperitoneally for seven days. Histopathological and immunohistochemical evaluations were conducted. RESULTS: Regarding Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, there was no significant difference among the groups. However, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) levels were significantly different across the groups. G2 had significantly higher NF-κB levels compared to G1 and G3. CONCLUSION: Lercanidipine, a third-generation calcium channel blocker, is effective against inflammatory responses induced in spinal cord injury. Further studies are required to determine its capability in preventing apoptosis or improving functional recovery. To the best of our knowledge, this study is the first in the literature to examine the neuroprotective effects of lercanidipine on spinal cord injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Tepecik Research and Training Hospital, University of Health Sciences, İzmir-Türkiye.
- Department of Neurosurgery, Faculty of Medicine, Amasya University, Amasya-Türkiye.
- Department of Histology and Embryology, Faculty of Medicine, Ege University, İzmir-Türkiye.
Zitieren
APA
Türk, Ç., Bahadır, S., Camlar, M., Gürel, Ç., Buhur, A., & Kuşçu, G. C. (2024). Effects of lercanidipine on traumatic spinal cord injury: an experimental study. Turkish Journal of Trauma and Emergency Surgery. https://doi.org/10.14744/tjtes.2024.03660
Vancouver
Türk Ç, Bahadır S, Camlar M, Gürel Ç, Buhur A, Kuşçu GC. Effects of lercanidipine on traumatic spinal cord injury: an experimental study. Turkish Journal of Trauma and Emergency Surgery. 2024. doi:10.14744/tjtes.2024.03660
BibTeX
@article{Trk2024,
author = {Türk, Çağlar and Bahadır, Sinan and Camlar, Mahmut and Gürel, Çevik and Buhur, Aylin and Kuşçu, Gökçe Ceren},
title = {Effects of lercanidipine on traumatic spinal cord injury: an experimental study},
journal = {Turkish Journal of Trauma and Emergency Surgery},
year = {2024},
doi = {10.14744/tjtes.2024.03660}
}
EUVIMED